Clinical
Ambelvist adds lower-dose GBCA option for MRI
FDA approval covers gadoquatrane for detecting and visualizing lesions with abnormal vascularity in CNS and non-CNS body regions across adult and pediatric patients.
Company
Bayer
Clinical
Bayer PET tracer meets cardiac amyloidosis endpoints
Bayer reported positive topline phase 3 REVEAL results for I-124 evuzamitide, an investigational PET/CT radiotracer for suspected cardiac amyloidosis. The study met its sensitivity and specificity endpoints.